Current through Vol. 42, No. 1, September 16, 2024
(a)
Designation of collection
site. Each urine drug testing program shall have one or more designated
collection sites which have all necessary personnel, materials, equipment,
facilities, and supervision to provide for the collection, security, temporary
storage, and shipping or transportation of urine specimens to a licensed drug
testing facility.
(b)
Security. Procedures shall provide for the designated collection
site to be secure. If a collection site facility is dedicated solely to urine
collection, it shall be secure at all times. If a facility cannot be dedicated
solely to drug testing, the portion of the facility used for testing shall be
secured during drug testing.
(c)
Chain of custody. Chain of custody standardized forms shall be
properly executed by authorized collection site personnel upon receipt of
specimens. Handling and transportation of urine specimens from one authorized
individual or place to another shall always be accomplished through chain of
custody procedures. Every effort shall be made to minimize the number of
persons handling specimens.
(e)
Privacy. Procedures for
collecting urine specimens shall allow individual privacy. No employer or
representative, agent or designee of the employer shall directly observe an
applicant or employee in the process of producing a urine sample, provided
collection occurs in a manner reasonably calculated to prevent substitutions or
interference with the collection or testing of reliable samples.
(f)
Integrity and identity of
specimen. Precautions shall be taken to ensure that a urine specimen is
not adulterated or diluted during the collection procedure and that information
on the urine specimen bottle and on the chain of custody form can identify the
individual from whom the specimen was collected. The following minimum
precautions shall be taken to ensure that unadulterated specimens are obtained
and correctly identified:
(1) To deter the
dilution of specimens at the collection site, toilet bluing agents shall be
placed in toilet tanks wherever possible, so the reservoir of water in the
toilet bowl always remains blue. There shall be no other source of water i.e.,
no shower or sink, in the enclosure where urination occurs.
(2) When an individual arrives at the
collection site, the collection site person shall request the individual to
present photo identification. If the individual does not have proper photo
identification, the collection site person shall contact the supervisor of the
individual, the coordinator of the drug testing program, or any other employer
official who can positively identify the individual. If the individual's
identity cannot be established, the collection site person shall not proceed
with the collection.
(3) If the
individual fails to arrive at the assigned time, the collection site person
shall contact the appropriate authority to obtain guidance on the action to be
taken.
(4) The collection site
person shall ask the individual to remove any unnecessary outer garments such
as a coat or jacket that might conceal items or substances that could be used
to tamper with or adulterate the individual's urine specimen. The collection
site person shall ensure that all personal belongings such as a purse or
briefcase remain with the outer garments. The individual may retain his or her
wallet.
(5) The individual shall be
instructed to wash and dry his or her hands prior to urination.
(6) After washing hands, the individual shall
remain in the presence of the collection site person and shall not have access
to any water fountain, faucet, soap dispenser, cleaning agent or any other
materials which may be used to adulterate the specimen.
(7) The individual may provide the specimen
in the privacy of a stall or otherwise partitioned area that allows for
individual privacy.
(8) The
collection site person shall note any unusual behavior or appearance on the
chain of custody form.
(9) In the
exceptional event that a drug testing program designated collection site is not
accessible and there is an immediate requirement for specimen collection (e.g.,
an accident investigation), a public rest room may be used according to the
following procedures: A collection site person of the same gender as the
individual shall accompany the individual into the public rest room which shall
be made secure during the collection procedure. If possible, a toilet bluing
agent shall be placed in the bowl and any accessible toilet tank. The
collection site person shall remain in the rest room, but outside the stall,
until the specimen is collected. If no bluing agent is available to deter
specimen dilution, the collection site person shall instruct the individual not
to flush the toilet until the specimen is delivered to the collection site
person. After the collection site person has possession of the specimen, the
individual shall be instructed to flush the toilet and to participate with the
collection site person in completing the chain of custody procedures.
(10) Upon receiving the specimen from the
individual, the collection site person shall determine that it contains at
least forty-five (45) ml of urine under the split sample method of collection
or thirty (30) ml of urine under the single sample method of collection.
(A) If drug testing is to be conducted in a
testing facility which performs both the initial screening test and the
confirmatory test at the same location, urine may be collected under either the
single sample method of collection, or the split sample method of
collection.
(B) If drug testing is
to be conducted in a testing facility which performs only the initial screening
test, the split sample method of collection shall be used.
(i)
Split sample collection
method.
(I) The donor shall urinate
into a container or a specimen bottle capable of holding at least sixty (60)
ml.
(II) If a collection container
is used, the collection site person, in the presence of the donor, pours the
urine into two specimen bottles. Thirty (30) ml shall be poured into one
bottle, to be used as the primary specimen. At least fifteen (15) ml shall be
poured into the other bottle, to be used as the split specimen.
(III) If a single specimen bottle is used as
a collection container, the collection site person shall pour thirty (30) ml of
urine from the specimen bottle into a second specimen bottle to be used as the
primary specimen and retain the remainder, i.e., at least fifteen (15) ml, in
the collection bottle to be used as the split specimen.
(IV) Both bottles shall be shipped in a
single shipping container to the testing facility.
(ii)
Single sample collection
method.
(I) The collection site person
may choose to direct the donor to urinate either directly into a specimen
bottle or into a separate collection container.
(II) If a separate collection container is
used, the collection site person shall pour at least thirty (30) ml of the
urine from the collection container into the specimen bottle in the presence of
the donor.
(C) In either collection methodology, upon
receiving the specimen from the donor, the collection site person shall
determine if it has at least thirty (30) ml of urine for the primary or single
specimen bottle, and where the split specimen collection method is used, an
additional fifteen (15) ml of urine for the split specimen bottle. If the
individual is unable to provide such a quantity of urine, the collection site
person shall instruct the individual to drink not more than twenty-four (24)
ounces of fluids and, after a period of up to two (2) hours, again attempt to
provide a complete sample using a fresh collection container. The original
insufficient specimen shall be discarded. If the donor is still unable to
provide an adequate specimen, the insufficient specimen shall be discarded,
testing discontinued, and an official of the drug testing program so
notified.
(11) After the
specimen has been provided and submitted to the collection site person, the
individual shall be allowed to wash his or her hands.
(12) Immediately after the specimen is
collected, the collection site person shall measure the temperature of the
specimen. The temperature measuring device used shall accurately reflect the
temperature of the specimen and not contaminate the specimen. The time from
urination to temperature measurement is critical and in no case shall exceed
four (4) minutes.
(13) If the
temperature of a specimen is outside the range of 32 -
37oC/90 - 100oF, that is
a reason to believe that the individual did alter or substitute the specimen,
and another specimen shall be collected under direct observation of a same
gender collection site person and both specimens shall be forwarded to the
testing facility for testing. An individual may volunteer to have an oral
temperature taken to provide evidence to counter the reason to believe the
individual did alter or substitute the specimen caused by the specimen's
temperature falling outside the prescribed range.
(14) Immediately after the specimen is
collected, the collection site person shall also inspect the specimen to
determine its color and look for any signs of contaminants such as unusual odor
or sudsing. Any unusual findings shall be noted on the chain of custody
form.
(15) All specimens suspected
of being adulterated shall be forwarded to the testing facility for
testing.
(16) Whenever there is
reason to believe that a particular individual did alter or substitute the
specimen provided, a second specimen shall be obtained as soon as possible
under the direct observation of a same gender collection site person.
(17) Both the individual being tested and the
collection site person shall keep the specimen in view at all times prior to
its being sealed and labeled. If the specimen is transferred to a second
bottle, the collection site person shall request the individual to observe the
transfer of the specimen and the placement of the tamper-proof seal over the
bottle cap and down the sides of the bottle.
(18) The collection site person and the
individual shall be present at the same time during procedures outlined in
paragraphs (f)(19) - (f)(22) of this section.
(19) The collection site person shall place
securely on the bottle an identification label which contains the date, the
individual's specimen number, and any other identifying information provided or
required by the drug testing program.
(20) The individual shall initial the
identification label on the specimen bottle for the purpose of certifying that
it is the specimen collected from the individual.
(21) The collection site person shall
indicate on the chain of custody form all information identifying the specimen.
The collection site person shall sign the chain of custody form next to the
identifying information.
(22) The
individual shall be asked to read and sign a statement certifying that the
specimen identified as having been collected from the individual is in fact
that specimen the individual provided.
(23) A higher level supervisor shall review
and concur in advance with any decision by a collection site person to obtain a
specimen under the direct observation of a same gender collection site person
based on a reason to believe that the individual did alter or substitute the
specimen provided.
(24) The
collection site person shall complete the chain of custody form.
(g)
Collection
control. To the maximum extent possible, collection site personnel shall
keep the individual's specimen bottle within sight both before and after the
individual has urinated. After the specimen is collected, it shall be properly
sealed and labeled. An approved chain of custody form shall be used for
maintaining control and accountability of each specimen from the point of
collection to final disposition of the specimen. The date and purpose shall be
documented on an approved chain of custody form each time a specimen is handled
or transferred and every individual in the chain shall be identified. Every
effort shall be made to minimize the number of persons handling
specimens.
(h)
Transportation
to the testing facility. Collection site personnel shall arrange to
transport the collected specimens to the drug testing facility. The specimens
shall be placed in containers designed to minimize the possibility of damage
during transport, for example, specimen boxes or padded mailers; and those
containers shall be securely sealed to eliminate the possibility of undetected
tampering. On the tape sealing the container, the collection site supervisor
shall sign and enter the date specimens were sealed in the container for
transfer. The collection site personnel shall ensure that the chain of custody
documentation is sealed separately from the specimen and placed inside the
container sealed for transfer to the drug testing facility.
Added at 11 Ok Reg 4339,
eff 7-14-94 (emergency); Added at 12 Ok Reg 517, eff 12-12-94 (emergency);
Added at 12 Ok Reg 3069, eff 7-27-95; Amended at 17 Ok Reg 381, eff 11-1-99
(emergency); Amended at 17 Ok Reg 2045, eff
6-12-00
